Skip to content

BMS-708163

DRUG11 trials

Sponsors

Bristol-Myers Squibb

Conditions

Alzheimer DiseaseAlzheimer's DiseaseHealthy

Phase 1

Drug Interaction Study With a Potential Alzheimer's Disease Compound
CompletedNCT00726726
Bristol-Myers SquibbAlzheimer Disease
Start: 2008-08-31End: 2008-10-31Updated: 2008-11-05
Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese
CompletedNCT00828646
Bristol-Myers SquibbHealthy
Start: 2008-10-31End: 2009-07-31Updated: 2011-01-07
Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole
CompletedNCT00860275
Bristol-Myers SquibbAlzheimer Disease
Start: 2009-04-30End: 2009-06-30Updated: 2011-01-25
Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease
CompletedNCT00901498
Bristol-Myers SquibbAlzheimer's Disease, Healthy
Start: 2009-05-31End: 2009-07-31Updated: 2011-01-07
Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects
CompletedNCT00979316
Bristol-Myers SquibbAlzheimer Disease
Start: 2009-09-30End: 2010-02-28Updated: 2011-01-07
Drug-Drug Interaction Study With Rifampin
CompletedNCT01002079
Bristol-Myers SquibbAlzheimer Disease
Start: 2010-08-31End: 2010-10-31Updated: 2011-01-25
Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)
CompletedNCT01039194
Bristol-Myers SquibbAlzheimer Disease
Start: 2010-01-31End: 2010-04-30Updated: 2011-01-25
Drug-Drug Interaction Study With Aricept® (Donepezil)
CompletedNCT01042314
Bristol-Myers SquibbAlzheimer Disease
Start: 2010-01-31End: 2010-04-30Updated: 2011-01-25
Multiple Dose Japanese Bridging Study
CompletedNCT01057030
Bristol-Myers SquibbAlzheimer Disease
Start: 2010-03-31End: 2010-06-30Updated: 2011-01-25
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163
CompletedNCT01079819
Bristol-Myers SquibbAlzheimer's Disease
Start: 2010-04-30End: 2010-12-31Updated: 2011-02-07

Phase 2

Related Papers